Filing Flows › Insmed (INSM) › How it makes money
How Insmed (INSM) makes money
Insmed (INSM) made $524M of revenue in the third quarter 2026 (Q3 2026), +268% from a year earlier. BRINSUPRI brought in $400M (76%); ARIKAYCE brought in $124M (24%).
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| BRINSUPRI | $400M | 76.3% | +29% | 14× |
| ARIKAYCE | $124M | 23.7% | +7% | +9% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $524M | 100.0% |
| Income tax | $2.7M | 0.5% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $524M | +268% |
| Q2 2026 | $425M | +296% |
| Q1 2026 | $306M | +230% |
| Q4 2025 | $264M | +153% |
| Q3 2025 | $142M | +52% |
| Q2 2025 | $107M | +19% |
| Q1 2025 | $92.8M | +23% |
From Insmed's 10-Q filed Oct 29, 2026 (on EDGAR).
Questions
How does Insmed make money?
Insmed (INSM) made $524M of revenue in the third quarter 2026 (Q3 2026), +268% from a year earlier. BRINSUPRI brought in $400M (76%); ARIKAYCE brought in $124M (24%).
What is Insmed's biggest business?
BRINSUPRI: $400M in the third quarter 2026, 76% of revenue, up 14-fold from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.